OneSource Specialty Pharma announced that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Sterile Product Division facility (SPD) of OneSource Specialty Pharma located at Opp.
The inspection has concluded with one observation. The Company will respond to the observation comprehensively to FDA within the stipulated time frame.